ArticleInternal and emergency medicine2026
Residual congestion and urinary sodium and chloride trajectories in acute heart failure.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Residual congestion remains frequent after initial treatment for acute heart failure (AHF), and its presence may not be adequately identified using individual clinical or biochemical markers. We investigated residual congestion using a multimodal approach and examined its relationship with changes in urinary sodium and chloride during the first 72 h of hospitalization. We prospectively included consecutive patients hospitalized for AHF who underwent congestion assessment at admission and 72 h. Clinical evaluation, NT-proBNP, and venous Doppler ultrasound (VExUS) were integrated to assess congestion. Residual multimodal congestion was defined by the presence of at least two of three criteria: VExUS score ≥ 1, < 30% reduction in NT-proBNP, and clinical congestion score ≥ 3. Urinary sodium and chloride were measured at admission and 72 h, and their changes over time were evaluated using linear mixed-effects models. Baseline estimated glomerular filtration rate (eGFR), worsening renal function, and urinary albumin-to-creatinine ratio were additionally characterized. Among 146 patients, 67 (45.9%) had residual multimodal congestion at 72 h. Urinary sodium and chloride concentrations were lower in patients with residual congestion. Both electrolytes decreased during the first 72 h (p < 0.001 for both), but their changes differed according to residual congestion status, with significant time-by-group interactions for sodium (p = 0.013) and chloride (p = 0.001). Patients with residual congestion also showed a trend toward poorer 180-day event-free survival, although this difference did not reach statistical significance (log-rank p = 0.078). Patients with residual congestion showed different early patterns of urinary sodium and chloride during treatment for AHF. Serial measurement of these electrolytes may complement clinical, biochemical, and venous ultrasound assessment when evaluating the response to decongestive therapy. These findings support their potential role in characterizing different decongestive profiles, although their clinical and prognostic value requires further evaluation.
Indexed as
Identifiers
42832026What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.